Avila-Luna, A.; Verduzco-Mendoza, A.; Olmos-Hernández, A.; Cortes-Altamirano, J.L.; Alfaro-RodrÃguez, A.; Arias-Montaño, J.-A.; Bueno-Nava, A.
The Interaction of Histamine H3 and Dopamine D1 Receptors on Hyperkinetic Alterations in Animal Models of Parkinson’s Disease. Pharmaceuticals 2024, 17, 1726.
https://doi.org/10.3390/ph17121726
AMA Style
Avila-Luna A, Verduzco-Mendoza A, Olmos-Hernández A, Cortes-Altamirano JL, Alfaro-RodrÃguez A, Arias-Montaño J-A, Bueno-Nava A.
The Interaction of Histamine H3 and Dopamine D1 Receptors on Hyperkinetic Alterations in Animal Models of Parkinson’s Disease. Pharmaceuticals. 2024; 17(12):1726.
https://doi.org/10.3390/ph17121726
Chicago/Turabian Style
Avila-Luna, Alberto, Antonio Verduzco-Mendoza, Adriana Olmos-Hernández, José Luis Cortes-Altamirano, Alfonso Alfaro-RodrÃguez, José-Antonio Arias-Montaño, and Antonio Bueno-Nava.
2024. "The Interaction of Histamine H3 and Dopamine D1 Receptors on Hyperkinetic Alterations in Animal Models of Parkinson’s Disease" Pharmaceuticals 17, no. 12: 1726.
https://doi.org/10.3390/ph17121726
APA Style
Avila-Luna, A., Verduzco-Mendoza, A., Olmos-Hernández, A., Cortes-Altamirano, J. L., Alfaro-RodrÃguez, A., Arias-Montaño, J.-A., & Bueno-Nava, A.
(2024). The Interaction of Histamine H3 and Dopamine D1 Receptors on Hyperkinetic Alterations in Animal Models of Parkinson’s Disease. Pharmaceuticals, 17(12), 1726.
https://doi.org/10.3390/ph17121726
